DNL

DIURNAL GROUP PLC ORD GBP0.05

TitleTime
Second Price Monitoring ExtnThu 30/04/20 | 09:05
Price Monitoring ExtensionThu 30/04/20 | 09:00
Director Dealings and Issue of EquityTue 21/04/20 | 10:05
Director DealingsThu 16/04/20 | 14:23
Second Price Monitoring ExtnWed 15/04/20 | 16:41
Price Monitoring ExtensionWed 15/04/20 | 16:36
Operational UpdateWed 15/04/20 | 07:00
Director DealingsMon 06/04/20 | 09:21
Chronocort MAA Passes Validation Stage with EMAWed 01/04/20 | 07:00
Holding(s) in CompanyMon 30/03/20 | 18:18
Holding(s) in CompanyFri 27/03/20 | 17:26
Director DealingsFri 27/03/20 | 09:17
US Licencing Agreement with Eton PharmaceuticalsFri 27/03/20 | 07:00
Second Price Monitoring ExtnThu 26/03/20 | 14:05
Price Monitoring ExtensionThu 26/03/20 | 14:00
Result of General Meeting and Issue of EquityWed 25/03/20 | 14:47
Second Price Monitoring ExtnFri 20/03/20 | 16:48
Price Monitoring ExtensionFri 20/03/20 | 16:39
Result of Placing and Notice of General MeetingFri 06/03/20 | 16:55
Proposed PlacingFri 06/03/20 | 11:22
Directorate ChangeThu 05/03/20 | 16:41
Holding(s) in CompanyTue 25/02/20 | 15:06
Second Price Monitoring ExtnThu 20/02/20 | 16:41
Price Monitoring ExtensionThu 20/02/20 | 16:36
Price Monitoring ExtensionThu 20/02/20 | 11:00
Holding(s) in CompanyMon 17/02/20 | 13:46
US FDA Accepts NDA Application for AlkindiThu 13/02/20 | 07:00
Interim ResultsTue 11/02/20 | 07:00
Business and trading updateMon 20/01/20 | 07:00
Holding(s) in CompanyMon 13/01/20 | 07:00
Notice of Interim ResultsMon 13/01/20 | 07:00
Director Dealings and Issue of EquityFri 10/01/20 | 15:45
Issue of Long-Term Incentive Plan awardsFri 10/01/20 | 15:44
Director DealingsMon 16/12/19 | 11:46
Chronocort MAA Submitted in EuropeMon 16/12/19 | 07:00
Share Option Exercise and Issue of EquityMon 02/12/19 | 14:28
Holding(s) in CompanyMon 02/12/19 | 07:01
Alkindi New Drug Application Submitted to US FDAMon 02/12/19 | 07:00
Director Dealings and Issue of EquityTue 26/11/19 | 10:42
Results of Annual General MeetingThu 21/11/19 | 13:08
AGM StatementThu 21/11/19 | 07:00
Successful outcome of testosterone clinical studyWed 20/11/19 | 07:00
Vesting of LTIP awardsFri 08/11/19 | 07:00
Issue of EquityMon 21/10/19 | 18:23
Director DealingsMon 21/10/19 | 13:09
Posting of Annual Report and AGM NoticeTue 08/10/19 | 11:26
Results for the year ended 30 June 2019Tue 24/09/19 | 07:00
Director DealingsWed 07/08/19 | 11:04
Director/PDMR ShareholdingMon 05/08/19 | 12:27
Holding(s) in CompanyFri 26/07/19 | 16:32
Director Dealings and Issue of EquityMon 08/07/19 | 14:07
Market Authorisation Application in AustraliaWed 03/07/19 | 07:00
Holding(s) in CompanyWed 26/06/19 | 15:57
Director DealingsMon 24/06/19 | 09:39
Holding(s) in CompanyFri 21/06/19 | 15:40
Holding(s) in Company - ReplacementFri 21/06/19 | 15:35
Change of AuditorFri 21/06/19 | 10:18
Holding(s) in CompanyWed 19/06/19 | 16:08
Director DealingsTue 18/06/19 | 14:03
Director DealingsMon 17/06/19 | 12:05
Result of General Meeting and Issue of EquityFri 14/06/19 | 12:39
Result of Open OfferFri 14/06/19 | 07:00
Placing, Open Offer and Notice of General MeetingTue 28/05/19 | 07:00
Intent to Submit for MAA tendered to the EMAThu 09/05/19 | 07:00
Notice of ResultsThu 02/05/19 | 15:29
Holding(s) in CompanyTue 30/04/19 | 15:40
Holding(s) in CompanyTue 30/04/19 | 14:43
Director Dealings and Issue of EquityFri 26/04/19 | 17:52
Holding(s) in CompanyFri 26/04/19 | 15:10
Grant of Orphan Drug Designation in AustraliaWed 24/04/19 | 07:00
Positive Scientific Advice from EMA for ChronocortThu 11/04/19 | 07:00
Diurnal signs marketing and distribution agreementThu 28/03/19 | 07:00
Interim ResultsThu 28/03/19 | 07:00
Update on Alkindi US developmentWed 20/03/19 | 07:00
Submission of MAA for Alkindi and Second PatentMon 25/02/19 | 07:00
Notice of Interim ResultsMon 11/02/19 | 11:00
Director DealingsThu 17/01/19 | 07:00
Statement regarding Price MovementThu 10/01/19 | 12:18
Grant of second US patent for ChronocortThu 10/01/19 | 07:00
Director Dealings and Issue of EquityMon 24/12/18 | 07:00
Director DealingsWed 12/12/18 | 16:02
Regulatory package for Scientific Advice in EuropeTue 11/12/18 | 07:00
Director/PDMR ShareholdingTue 04/12/18 | 13:08
Results of Annual General MeetingWed 14/11/18 | 11:38
Issue of Equity and Exercise of OptionsWed 14/11/18 | 10:16
Update on late-stage development pipelineWed 17/10/18 | 07:00
Posting of Annual Report and AGM NoticeMon 08/10/18 | 16:00
SMC Approves The Use of AlkindiMon 08/10/18 | 14:45
Headline Data for Chronocort European Phase IIIMon 08/10/18 | 07:00
First patients enrolled in US Chronocort Phase IIIFri 05/10/18 | 07:00
Results for the year ended 30 June 2018Thu 20/09/18 | 07:00
Update on Alkindi® in GermanyWed 15/08/18 | 11:11
Director/PDMR ShareholdingTue 10/07/18 | 13:36
Notice of ResultsThu 21/06/18 | 07:00
Director/PDMR ShareholdingMon 18/06/18 | 16:54
Director DealingsFri 18/05/18 | 15:33
Appointment of NOMAD and Joint BrokerFri 18/05/18 | 13:11
Launch of Alkindi for paediatric AI in GermanyTue 15/05/18 | 08:13
Director DeclarationFri 11/05/18 | 14:41
Holding(s) in CompanyTue 17/04/18 | 15:58
Director/PDMR ShareholdingThu 05/04/18 | 14:08
Director/PDMR ShareholdingThu 05/04/18 | 08:01
Result of GM and Completion of £10.5m PlacingTue 03/04/18 | 14:39
Placing UpdateTue 20/03/18 | 17:20
Proposed PlacingWed 14/03/18 | 08:47
Appointment of CRO to support US Chronocort trialsMon 12/03/18 | 07:00
Half-year ReportMon 12/03/18 | 07:00
Diurnal announces grant of first patents in JapanThu 22/02/18 | 07:00
Commercialisation agreement in Australia and NZMon 19/02/18 | 07:00
European marketing authorisation for Alkindi®Tue 13/02/18 | 07:00
Completion of patient enrolment in EU Phase IIIMon 12/02/18 | 07:00
Positive results from Alkindi food matrix studyTue 09/01/18 | 07:00
Business Update and Notice of Interim ResultsTue 09/01/18 | 07:00
Issue of EquityFri 05/01/18 | 17:06
Replacement - Director DealingsFri 05/01/18 | 17:04
Diurnal receives positive CHMP opinion for AlkindiFri 15/12/17 | 12:50
CHMP positive opinion for Alkindi® (Infacort®)Fri 15/12/17 | 12:11
Total Voting RightsFri 08/12/17 | 11:30
Director/PDMR ShareholdingWed 29/11/17 | 12:20
Result of AGMTue 21/11/17 | 12:00
Director Dealing and Issue of EquityThu 09/11/17 | 18:19
Director/PDMR ShareholdingWed 08/11/17 | 12:00
Posting of Annual Report and AGM NoticeFri 13/10/17 | 09:00
Director DealingsThu 07/09/17 | 14:51
Grant of first US patent for Chronocort®Wed 06/09/17 | 07:00
Results for the year ended 30 June 2017Wed 06/09/17 | 07:00
Notice of Final ResultsMon 14/08/17 | 10:00
First Patient Dosed in US Infacort Clinical TrialThu 15/06/17 | 07:00